A provision of the “Inflation Reduction Act” (IRA) could threaten investments in "small molecule" drug development, said the Missouri-based president of The Latino Coalition.
There were nine companies in the City of St. Louis that received nine FDA inspections in the fourth quarter of 2023, according to the U.S. Food and Drug Association.
There were two companies in the City of St. Louis that received FDA citations as a result of two inspections conducted in the city over the first quarter of 2024, according to reports from the U.S. Food and Drug Administration (FDA).
New credit card regulations sponsored by U.S. Sen. Josh Hawley (R-Mo.) could threaten Missouri’s $19.9 billion tourism industry, said David Williams, president of the Taxpayers Protection Alliance (TPA).
There were two companies in the City of St. Louis that received FDA citations as a result of two inspections conducted in the city in March, according to reports from the U.S. Food and Drug Administration (FDA).